SPECCHIA, GIORGINA
 Distribuzione geografica
Continente #
NA - Nord America 2.946
EU - Europa 2.225
AS - Asia 1.888
SA - Sud America 216
AF - Africa 24
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.309
Nazione #
US - Stati Uniti d'America 2.921
CN - Cina 940
IE - Irlanda 710
UA - Ucraina 604
SG - Singapore 448
SE - Svezia 384
RU - Federazione Russa 229
BR - Brasile 188
HK - Hong Kong 188
TR - Turchia 158
FI - Finlandia 98
GB - Regno Unito 77
IN - India 68
VN - Vietnam 43
DE - Germania 30
IT - Italia 30
FR - Francia 27
AR - Argentina 14
CA - Canada 14
CZ - Repubblica Ceca 9
MX - Messico 9
ZA - Sudafrica 9
AT - Austria 8
IQ - Iraq 7
PK - Pakistan 6
PL - Polonia 6
AU - Australia 5
BD - Bangladesh 5
LT - Lituania 5
EU - Europa 4
JP - Giappone 4
DZ - Algeria 3
ES - Italia 3
KE - Kenya 3
MA - Marocco 3
UZ - Uzbekistan 3
VE - Venezuela 3
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
ID - Indonesia 2
JM - Giamaica 2
LB - Libano 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BE - Belgio 1
BN - Brunei Darussalam 1
CH - Svizzera 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
NG - Nigeria 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
UY - Uruguay 1
Totale 7.309
Città #
Dublin 708
Chandler 503
Jacksonville 425
Dearborn 357
Nanjing 263
Nyköping 210
Singapore 195
Hong Kong 188
Beijing 127
Nanchang 118
Ashburn 96
Santa Clara 91
San Mateo 86
Princeton 85
Boardman 78
Wilmington 75
Moscow 64
Dallas 53
Shenyang 49
Jiaxing 42
Kunming 40
Tianjin 40
The Dalles 35
Woodbridge 26
Hebei 25
Hangzhou 21
Changsha 20
Des Moines 19
Zhengzhou 19
Jinan 17
New York 16
Guangzhou 14
Ho Chi Minh City 14
Changchun 13
Los Angeles 12
Shanghai 12
São Paulo 12
Helsinki 11
Munich 11
Ningbo 11
Auburn Hills 10
Chicago 9
Lanzhou 8
London 8
Rio de Janeiro 8
Charlotte 7
San Francisco 7
Brooklyn 6
Chennai 6
Hilden 6
Johannesburg 6
Norwalk 6
Toronto 6
Wuhan 6
Belo Horizonte 5
Brasília 5
Brno 5
Hanoi 5
Monza 5
Taizhou 5
Turku 5
Warsaw 5
Atlanta 4
Boston 4
Leawood 4
Milan 4
Olomouc 4
Pelotas 4
Ann Arbor 3
Campo Grande 3
Caxias do Sul 3
Curitiba 3
Goiânia 3
Jinhua 3
Porto Alegre 3
Pune 3
Ribeirão Preto 3
San Giorgio Ionico 3
Secaucus 3
Shaoxing 3
Sorocaba 3
São Leopoldo 3
Tashkent 3
Tokyo 3
Aracaju 2
Augusta 2
Berazategui 2
Betim 2
Blida 2
Brisbane 2
Buffalo 2
Cabo Frio 2
Camden 2
Casablanca 2
Chatsworth 2
Cremona 2
Da Nang 2
Delhi 2
Erbil 2
Florianópolis 2
Totale 4.444
Nome #
T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. 133
Mobilization of haematopoietic stem cells CD34+ in patients undergoing elective lung resection: observational pilot study 123
Autoimmune myelofibrosis: report of three cases and review of the literature. 121
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). 115
Acute megakaryoblastic leukemia: experience of GIMEMA trials. 112
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. 108
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. 107
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 106
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. 104
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature 101
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment. 98
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. 97
Acute mixed lineage leukemias. 97
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. 97
Extramedullary blast crisis in chronic myeloid leukemia 97
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 96
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 95
Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia. 94
Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. 93
t(15;17) in acute promyelocytic leukemia is not associated with submicroscopic deletions on der(17) 93
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. 93
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. 92
Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21). 92
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 92
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. 91
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. 91
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. 90
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. 90
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. 90
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia. 89
A case of Sezary's syndrome with terminal "leukemic phase". 88
Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease. 88
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. 88
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. 86
Non-treatment-related chronic myeloid leukemia as a second malignancy. 86
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 86
Cytochemical "normal" and "abnormal" eosinophils in acute leukemias. 85
Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. 85
Acute promyelocytic leukemia: morphological aspects. 84
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. 84
Pneumonia in acute leukemia patients during induction therapy: experience in a single institution. 84
Molecular cytogenetic study of chromosomal instability at 1q21-32 in an adult acute lymphoblastic leukemia case. 83
Fungemia in acute leukemia patients: a single institution's experience. 83
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. 83
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia. 83
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 82
Familial clustering of HTLV-I infection in southeastern Italy 82
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells. 82
Sensitivity to imatinib but low frequency of the TEL/PDGFRb fusion protein in chronic myelomonocytic leukemia. 82
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a Ph-positive chronic myeloid leukemia. 81
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 81
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes. 81
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. 80
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia. 80
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. 80
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukaemia. 80
Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. 80
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. 79
Typhlitis complicating induction therapy in adult acute myeloid leukemia. 79
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. 78
Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome? 78
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? 78
Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. 77
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears 77
Cytophagocytosis by the blast cells in acute myeloid leukemia. 77
The MDR phenotype in acute nonlymphoid leukemia. 77
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia. 76
Genomic deletions on the third chromosome involved in variant t(9;22) chronic myeloid leukaemia cases 76
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. 75
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. 75
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. 75
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. 74
Monocytes with binding capacity to sheep red blood cells in a case of acute undifferentiated leukemia. 74
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia. 73
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. 73
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA 72
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. 72
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two cases. 71
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. 71
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. 71
Therapy of molecular relapse in acute promyelocytic leukemia. 70
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. 67
Hand-mirror (HM) cells in acute lymphoblastic leukaemia (A.L.L.). An attempt at cellular classification by morphometric analytical parameters using the S.A.M. (Shape Analytical Morphometry) system. 67
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. 62
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias 62
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 51
Totale 7.351
Categoria #
all - tutte 37.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 93 88 7 87 98 2 4
2021/2022386 84 0 0 1 11 4 8 28 67 40 25 118
2022/20231.929 136 56 50 171 158 176 0 176 915 8 49 34
2023/2024246 78 11 16 16 28 49 3 12 3 1 2 27
2024/20251.130 50 7 6 53 44 149 135 60 315 88 106 117
2025/2026612 81 72 131 205 87 36 0 0 0 0 0 0
Totale 7.351